Fundz

H Cyte, Inc. reported raising $6 Million in an initial SEC Form D filing, from an offering of $9.75 Million

PRIVATENov 27, 2019$6M of $9.8M raised

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Nov 27, 2019)

Round Type

Venture

TampaBiotechnologyHealthcareHealth CareMedical

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as H-CYTE, INC. that raised within 45 days of this round, from Fundz verified event records.

  • ORTHALIGN INC raised $3.2M (Seed) on January 9, 2020.
  • Savara Inc raised $27M on January 2, 2020.
  • Kinnate Biopharma raised $74M on December 23, 2019.
  • Clarapath raised $36M on December 2, 2019.
  • Amwell raised $32M on November 27, 2019.
  • Vektor Medical raised $3.6M (Seed) on November 15, 2019.

Who to call at H-CYTE, INC., and when

A new round usually means H-CYTE, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day H-CYTE, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at H-CYTE, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at H-CYTE, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

H-CYTE, INC.

Location

201 E KENNEDY BLVD SUITE 700

Tampa, Florida, United States

About

H-CYTE is a medical biosciences company. H-CYTE’s mission is to become a leader in next-generation, cellular therapeutics for the treatment of chronic health conditions, with the ultimate goal of improving patient lives. For more information about H-CYTE, please visit www.HCYTE.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment H-CYTE, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for H-CYTE, INC.'s next move

See what Strategic adds

H-CYTE, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.